No connection

Search Results

JNJ vs SIGA

JNJ
Johnson & Johnson
NEUTRAL
Price
$237.96
Market Cap
$573.46B
Sector
Healthcare
AI Confidence
85%
SIGA
SIGA Technologies, Inc.
BEARISH
Price
$4.76
Market Cap
$341.0M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
JNJ
21.55
SIGA
14.88
Forward P/E
JNJ
18.9
SIGA
3.24
P/B Ratio
JNJ
7.03
SIGA
1.71
P/S Ratio
JNJ
6.09
SIGA
3.61
EV/EBITDA
JNJ
17.81
SIGA
7.7

Profitability

Gross Margin
JNJ
68.08%
SIGA
47.49%
Operating Margin
JNJ
23.97%
SIGA
-250.38%
Profit Margin
JNJ
28.46%
SIGA
24.62%
ROE
JNJ
35.03%
SIGA
11.23%
ROA
JNJ
8.68%
SIGA
6.39%

Growth

Revenue Growth
JNJ
9.1%
SIGA
-95.3%
Earnings Growth
JNJ
48.6%
SIGA
--

Financial Health

Debt/Equity
JNJ
0.6
SIGA
0.0
Current Ratio
JNJ
1.03
SIGA
11.83
Quick Ratio
JNJ
0.69
SIGA
8.79

Dividends

Dividend Yield
JNJ
2.19%
SIGA
--
Payout Ratio
JNJ
46.6%
SIGA
0.0%

AI Verdict

JNJ NEUTRAL

JNJ presents a dichotomy between strong profitability and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the company maintains an impressive ROE of 35.03% and a consistent history of earnings beats, the current price of $237.96 trades at a significant premium to its Graham Number of $91.72. Growth remains robust on a YoY basis, but bearish insider sentiment and a very weak technical trend (10/100) suggest immediate headwinds. The stock is fundamentally sound in terms of earnings power but shows signs of operational inefficiency or declining quality in its deterministic health metrics.

Strengths
Exceptional Return on Equity (ROE) of 35.03%
Strong profit margins (28.46%) and gross margins (68.08%)
Consistent earnings beat track record over 25 quarters
Risks
Weak Piotroski F-Score (3/9) indicating declining fundamental health
Bearish insider activity with $58.35M in net sales and zero buys
Low liquidity indicated by a Quick Ratio of 0.69
SIGA BEARISH

SIGA presents a stark contrast between a pristine balance sheet and a collapsing operational core, evidenced by a Piotroski F-Score of 4/9 (Stable). While the company maintains zero debt and an exceptional current ratio of 11.83, the YoY revenue decline of -95.30% and an operating margin of -250.38% indicate a severe crisis in business continuity. The current price of $4.76 trades at a premium to both the Graham Number ($4.47) and the Intrinsic Value ($2.24), suggesting the stock is overvalued relative to its fundamentals. Technical trends are fully bearish, and the earnings track record shows a consistent failure to meet analyst expectations.

Strengths
Zero debt (Debt/Equity: 0.00)
Extremely high liquidity (Current Ratio: 11.83)
Strong gross margins (47.49%)
Risks
Catastrophic revenue collapse (-95.30% YoY)
Severe operating losses (Operating Margin: -250.38%)
Consistent earnings misses (0/4 beats in last 4 quarters)

Compare Another Pair

JNJ vs SIGA: Head-to-Head Comparison

This page compares Johnson & Johnson (JNJ) and SIGA Technologies, Inc. (SIGA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile